Skip Navigation

European Heart Journal 2001 22(17):1561-1571; doi:10.1053/euhj.2000.2515
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kamath, S.
Right arrow Articles by Lip, G.Y.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamath, S.
Right arrow Articles by Lip, G.Y.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review Article

Platelet activation: assessment and quantification

S. Kamath, A.D. Blann and G.Y.H. Lipf1

Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, U.K.

revised October 24, 2000; accepted October 25, 2000

Key Words: Platelets, thrombosis, thromboembolism, antiplatelet therapy

f1 Correspondence: Dr G. Y. H. Lip, Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, U.K.

References

  1. Hoak JC. Platelet and atherosclerosis. Semin Thromb Hemost. 1988;14:202–205[Web of Science][Medline]
  2. Rabbani LE, Loscalzo J. Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque. Atherosclerosis. 1994;105:1–7[CrossRef][Web of Science][Medline]
  3. White JG. Platelets and atherosclerosis. Eur J Clin Invest. 1994;24:25–29
  4. Falk E, Fernandez-Ortiz A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol. 1995;75:3B–11B[CrossRef][Medline]
  5. Mustard JF, Packham MA. The role of blood and platelets in arteriosclerosis and the complications of atherosclerosis. Thromb Diathesis Haemmorhage. 1975;33:444–456
  6. Mustard JF, Packham MA, Rowsell HX, Jorgensen L. The role of thrombogenic factors in atherosclerosis. Ann NY Acad Sci. 1968;149:848–859[CrossRef][Web of Science][Medline]
  7. Tschoepe D, Roesen P, Esser J. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost. 1991;17:433–438[Web of Science][Medline]
  8. Maly J, Pecka M, Vodckova L. Changes in the activity of thrombocytes by smoking. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1990;33:325–333[Medline]
  9. Buring JE, Hennekens CH. Prevention of cardiovascular disease: risks and benefits of aspirin. J Gen Intern Med. 1990;5:S54–57[Medline]
  10. Schellinger PD, Orberk E, Hacke W. Antithrombotic therapy after cerebral ischaemia. Fortschr Neurol Psychiatr. 1997;65:425–434[Web of Science][Medline]
  11. George JN. Platelets. Lancet. 2000;355:1531–1539[CrossRef][Web of Science][Medline]
  12. Bautista AP, Buckler PW, Towler HM, Dawson AA, Bennett B. Measurement of platelet life span in normal subjects and patients with myeloproliferative disease with indium oxine labelled-platelets. Br J Haematol. 1984;58:679–687[Web of Science][Medline]
  13. Felder R, Banton V, Sayre D, Costa J, Baldini M, Kim B. Direct imaging of live human platelets by flash X-ray microscopy. Science. 1985;227:63–64[Abstract/Free Full Text]
  14. Avraham H. Regulation of megakaryocytopoiesis. Stem Cells. 1993;11:499–500[Web of Science][Medline]
  15. Kaushansky K. Thrombopoietin and hematopoietic stem cell development. Ann NY Acad Sci. 1999;872:314–319[CrossRef][Web of Science][Medline]
  16. Vizcaino-Salazar G. Platelet physiology. Advances in platelet reactivity. Rev Invest Clin. 1994;35:41–62
  17. McEver RP. The clinical significance of platelet membrane glycoproteins. Hematol Oncol Clin North Am. 1990;4:87–105[Web of Science][Medline]
  18. Okumura T, Jamieson GA. Platelet glycoprotein. I. Orientation of glycoproteins of the human platelet surface. J Biol Chem. 1976;251:5944–5949[Abstract/Free Full Text]
  19. Krejsek J, Loudova M, Kopecky O. Blood platelet adhesion molecules. Cas Lek Cesk. 1997;136:624–626[Medline]
  20. Packham MA. Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol. 1994;72:278–284[Web of Science][Medline]
  21. Kainoh M, Ikeda Y, Nishio S, Nakadate T. Glycoprotein Ia/IIa-mediated activation-dependent platelet adhesion to collagen. Thromb Res. 1992;65:165–176[CrossRef][Web of Science][Medline]
  22. Suzuki H, Yamazaki H, Tanoue K. Platelet structure and function: immunocytochemical localizations of membrane glycoprotein and alpha granule protein. Nippon Rinsho. 1992;50:218–222[Medline]
  23. Moroi M, Jung SM. Integrin mediated platelet adhesion. Front Biosci. 1998;3:719–728
  24. Johnston GI, Bliss GA, Newman PJ, McEver RP. Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes. J Biol Chem. 1990;265:21381–21385[Abstract/Free Full Text]
  25. McEver RP. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells. 1990;16:73–80[Web of Science][Medline]
  26. Larsen E, Celi A, Gilbert GE. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 1989;59:305–312[CrossRef][Web of Science][Medline]
  27. Johnston GI, Kurosky A, McEver RP. Structural and biosynthetic studies of the granule membrane protein, GMP-140, from human platelets and endothelial cells. J Biol Chem. 1989;264:1816–1823[Abstract/Free Full Text]
  28. Crovello CS, Furie BC, Furie B. Rapid phosphorylation and selective dephosphorylation of P-selectin accompanies platelet activation. J Biol Chem. 1993;268:14590–14593[Abstract/Free Full Text]
  29. Hsu-Lin SC, Berman CL, Furie BC, August D, Furie B. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monocloncal antibody specific for thrombin-activated platelets. J Biol Chem. 1984;259:9121–9126[Abstract/Free Full Text]
  30. Blann AD, Lip GYH. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis. 1997;128:135–138[CrossRef][Web of Science][Medline]
  31. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood. 1990;75:550–554[Abstract/Free Full Text]
  32. Geng JG, Bevilacqua MP, Moore KL. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature. 1990;343:757–760[CrossRef][Medline]
  33. Palabrica T, Lobb R, Furie BC. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848–851[CrossRef][Medline]
  34. Fox JE, Boyles JK, Berndt MC, Steffen PK, Anderson LK. Identification of a membrane skeleton in platelets. J Cell Biol. 1988;106:1525–1538[Abstract/Free Full Text]
  35. Rosing J, Van Rijn JL, Beevers EM. The role of activated human platelets in prothrombin and factor X activation. Blood. 1985;65:319–332[Abstract/Free Full Text]
  36. Fukami MH, Salganicoff L. Human platelet storage organelles. A review. Thromb Haemost. 1977;38:963–970[Web of Science][Medline]
  37. McLaren KM, Pepper DS. Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets. J Clin Pathol. 1982;35:1227–1231[Abstract/Free Full Text]
  38. Beggs GS, Pepper DS, Chesterman CN. Complete covalent structure of human beta thromboglobulin. Biochemistry. 1978;17:1739–1744[CrossRef][Medline]
  39. Morgan FJ, Begg GS, Chesterman CN. Complete covalent structure of human platelet factor 4. Thromb Haemost. 1980;42:1652–1660[Web of Science][Medline]
  40. Cella G, Scattolo N, Girolami A, Sasahara AA. Are platelet factor 4 and beta-thromboglobulin markers of cardiovascular disorders? Ric Clin Lab. 1984;14:9–18[Web of Science][Medline]
  41. Capitanio AM, Niewiarowski S, Rucinski B. Interaction of platelet factor 4 with human platelets. Biochem Biophys Acta. 1985;839:161–173[Medline]
  42. Walz DA. Thrombospondin as a mediator of cancer cell adhesion in metastasis. Cancer Metastasis Rev. 1992;11:313–324[CrossRef][Web of Science][Medline]
  43. Agam G, Shohat O, Livne A. Thrombospondin plays a role in platelet-platelet recognition during release-related aggregation. Proc Soc Exp Biol Med. 1984;177:482–486[CrossRef][Medline]
  44. Dawes J, Pratt DA, Dewar MS, Preston FE. Do extra-platelet sources contribute to the plasma level of thrombospondin? Thromb Haemost. 1988;59:273–276[Web of Science][Medline]
  45. White JG, Clawson CC. Biostructures of blood platelets. Ultrastruct Pathol. 1980;1:533–558[Web of Science][Medline]
  46. Gachet C, Cazenave JP. ADP induced blood platelet activation: a review. Nouv Rev Fr Hematol. 1991;33:347–358
  47. Seiss W. Molecular mechanisms of platelet activation. Physiol Rev. 1989;69:58–178[Free Full Text]
  48. Sixma JJ, Hindriks G, Van Breugel H. Vessel wall proteins adhesive for platelets. J Biomater Sci Polym Ed. 1991;3:17–26[Medline]
  49. Nurden AT, Bihour C, Macchi L. Platelet activation in thrombotic disorders. Nouv Rev Fr Hematol. 1993;35:67–71
  50. Kawai Y, Handa M, Nagai H. Role of membrane glycoproteins in the interaction of blood platelets with the vessel wall—the study on platelet adhesion to in vitro cultured subendothelial matrix. Nippon Ketsueki Gakkai Zasshi. 1989;52:1312–1321[Medline]
  51. Packham MA, Mustard JF. Platelet adhesion. Prog Hemost Thromb. 1984;7:211–288[Web of Science][Medline]
  52. Reinders JH, de Groot PG, Sixma JJ, Van Mourik JA. Storage and secretion of von Willebrand factor by endothelial cells. Haemostasis. 1988;18:246–261[Web of Science][Medline]
  53. Meyer D. Von Willebrand factor and platelet adhesion to the subendothelium of the vascular wall. Nouv Rev Fr Hematol. 1982;24:145–151
  54. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction. Does it exist? Br J Haematol. 1995;90:244–248[Web of Science][Medline]
  55. Ruggeri ZM, De Marco L, Gatti L, Bader R, Montgomery RR. Platelets have more than one binding site for von Willebrand factor. J Clin Invest. 1983;72:1–12[Web of Science][Medline]
  56. Danton MC, Zaleski A, Nichols WL, Olson JD. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid phase von Willebrand factor. J Lab Clin Med. 1994;124:274–282[Web of Science][Medline]
  57. Fleming TG. Von Willebrand factor: its function and its measurement in the laboratory. Br J Biomed Sci. 1995;52:50–57[Web of Science][Medline]
  58. Blann AD, Adams RA, Katai F, Ashleigh R, Taberner DA. Haematology and coagulation indices in paired samples of arterial and venous blood from patients with arterial disease. Haemostasis. 1996;26:72–78[Web of Science][Medline]
  59. White JG. Shape change. Thromb Diath Haemorrh. 1974;60:159–171
  60. Ehrman M, Tooth ME, Frojmovic M. A platelet procoagulant activity associated with platelet shape change. J Lab Clin Med. 1978;92:393–401[Web of Science][Medline]
  61. Kinlough-Rathbone RL, Mustard JF, Packham MA. Properties of washed human platelets. Thromb Haemost. 1977;37:291–308[Web of Science][Medline]
  62. McManama G, Lindon JN, Kloczewiak M. Platelet aggregation by fibrinogen polymers crosslinked across the E domain. Blood. 1986;68:363–371[Abstract/Free Full Text]
  63. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA. 1975;72:2994–2998[Abstract/Free Full Text]
  64. Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci USA. 1974;71:345–349[Abstract/Free Full Text]
  65. Holmsen H, Day HJ, Stormorken H. The blood platelet release reaction. Scand J Haematol Suppl. 1969;8:1–26
  66. Holt JC, Niewiarowski S. Biochemistry of {alpha} granule proteins. Semin Hematol. 1985;22:151–163[Web of Science][Medline]
  67. Kaplan KL, Broekman MJ, Chernoff A, Lesznik GR, Drillings M. Platelet alpha granule proteins: studies on release and subcellular localization. Blood. 1979;53:604–618[Free Full Text]
  68. Smith JB, Ingerman C, Kocsis JJ, Silver MJ. Formation of prostaglandins during the aggregation of human blood platelets. J Clin Invest. 1973;52:965–969[Web of Science][Medline]
  69. Smith WL, Marnett LJ, De Witt DL. Prostaglandin and thromboxane biosynthesis. Pharmacol Ther. 1991;49:153–179[CrossRef][Web of Science][Medline]
  70. Holmsen H. Prostaglandin, endoperoxide-thromboxane synthesis and dense granule secretion as positive feedback loops in the propagation of platelet responses during the ‘basic platelet reaction’. Thromb Haemost. 1977;38:1030–1041[Web of Science][Medline]
  71. Altman R, Scazziota A, Rouvier J, Cacchione R. Synergistic actions of PAF acether and sodium arachidonate in human platelet aggregation. Studies in normal human platelet rich plasma. Thromb Res. 1986;43:103–111[CrossRef][Web of Science][Medline]
  72. Ardlie NG, Bell LK, McGuiness JA. Synergistic potentiation by epinephrine of collagen or thrombin-induced calcium mobilization in human platelets. Thromb Res. 1987;46:519–526[CrossRef][Web of Science][Medline]
  73. Bushfield M, Mcnicol MA, Macintyre DE. Possible mechanisms of the potentiation of blood platelet activation by adrenaline. Biochem J. 1987;241:671–676[Web of Science][Medline]
  74. Sakuma I, Akaishi Y, Fukao M, Makita Y, Makita MA. Dipyridamole potentates the anti-aggregating effect of endothelium derived relaxing factor. Thromb Res Suppl. 1990;12:87–90[Medline]
  75. Hemker HC, van Rijn JL, Rosing J. Platelet membrane involvement in blood coagulation. Blood Cells. 1983;9:303–317[Web of Science][Medline]
  76. Walsh PN, Biggs R. The role of platelets in intrinsic factor-Xa formation. Br J Haematol. 1972;22:743–760[Web of Science][Medline]
  77. White AM, Heptinstall S. Contribution of platelets to thrombus formation. Br Med Bull. 1978;34:123–128[Free Full Text]
  78. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterisation of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen and convulxin. Blood. 2000;95:1694–1702[Abstract/Free Full Text]
  79. Grigg AP, Dauer R, Thurlow PJ. Bleeding due to an acquired inhibitor of platelet associated factor V. Aus NZ J Med. 1989;19:310–314[Web of Science][Medline]
  80. Padoin E, Alexandre A, Cavallini L, Polverino de Laureto P, Rao GH, Doni MG. Human platelet activation is inhibited by the occupancy of glycoprotein IIb-IIIa receptor. Arch Biochem Biophys. 1996;333:407–413[CrossRef][Web of Science][Medline]
  81. Ahmad SS, Rawala-Sheikh R, Walsh PN. Platelet receptor occupancy with factor IXa promotes factor X activation. J Biol Chem. 1989;264:20012–20016[Abstract/Free Full Text]
  82. Ellis EF, Eright KF, Jones PS, Richardson DW, Ellis CK. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin synthesis in human and rabbits. J Cardiovasc Pharmacol. 1980;2:387–397[Web of Science][Medline]
  83. Schafer AI. Antiplatelet Therapy. Am J Med. 1996;101:199–209[CrossRef][Web of Science][Medline]
  84. McElroy FA, Philip RB. Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotidesphosphodiesterases. Life Sci. 1975;75:1479–1493
  85. Ukawa H, Yamakuni H, Kato S, Takeuchi K. Effects of cyclooxygenase-2 selective and nitric oxide-releasing non-steroidal anti-inflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Digest Dis Sci. 1998;43:2003–2011
  86. Awtry EA, Loscalzo J. Cardiovascular Drugs—Aspirin. Circulation. 2000;101:1206[Free Full Text]
  87. Duguid JB. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J Pathol Bacteriol. 1946;58:207–212[CrossRef][Web of Science]
  88. Cahill MR, Newland AC. Platelet activation in coronary artery disease. Br J Biomed Sci. 1993;50:221–234[Web of Science][Medline]
  89. Grau AJ, Ruf A, Vogt A. Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost. 1998;80:298–301[Web of Science][Medline]
  90. Minamino T, Kitakaze M, Asanuma H. Plasma adenosine levels and platelet activation in patients with atrial fibrillation. Am J Cardiol. 1999;83:194–198[CrossRef][Web of Science][Medline]
  91. Sevush S, Jy W, Horstman LL, Mao WW, Kolodny L, Ahn YS. Platelet activation in Alzheimer Disease. Arch Neurol. 1998;55:530–536[Abstract/Free Full Text]
  92. Collins CE, Cahill MR, Newland AC, Rampton DS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology. 1994;106:840–845[Web of Science][Medline]
  93. De Boer AC, Han P, Turpie AG, Butt R, Zielinsky A, Genton E. Plasma and urine beta thromboglobulin concentrations in patients with deep vein thrombosis. Blood. 1981;58:693–698[Abstract/Free Full Text]
  94. Bonnar J. Coagulation effects of oral contraception. Am J Obstet Gynecol. 1987;157:1042–1048[Web of Science][Medline]
  95. Fisher M, Levine PH, Fullerton AL. Marker proteins of platelet activation in patients with cerebrovascular disease. Arch Neurol. 1982;39:692–695[Abstract/Free Full Text]
  96. Fareed J, Bick RL, Squillaci G, Walenga JM, Bermes EW Jr. Molecular markers of hemostatic disorders: implications in the diagnosis and therapeutic management of thrombotic and bleeding disorders. Clin Chem. 1983;29:1641–1658[Abstract/Free Full Text]
  97. Klotz TA, Cohn LS, Zipser RD. Urinary excretion of thromboxane B2 in patients with venous thromboembolic disease. Chest. 1984;85:329–335[Abstract/Free Full Text]
  98. Holmsen H. Significance of testing platelet functions in vitro. Eur J Clin Invest. 1994;24:3–8
  99. Milton JG, Frojmovic MM. Turbidometric evaluation of platelet activation. Relative contributions of measured shape change, volume and early aggregation. J Pharmacol Methods. 1983;9:101–115[CrossRef][Web of Science][Medline]
  100. Bamber E, Bauer O, Herrmann W. Primary shape change of platelets in vitro. Blut. 1978;37:327–339[CrossRef][Web of Science][Medline]
  101. Watts SE, Tunbridge LJ, Smith K, Lloyd JV. Storage of platelets for test of platelet function: effects of temperature on platelet aggregation platelet morphology and liberation of beta thromboglobulin. Thromb Res. 1986;44:365–376[CrossRef][Web of Science][Medline]
  102. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927–929[Medline]
  103. Chen YC, Wu KK. A comparison of methods for the study of platelet hyperfunction in thromboembolic disorders. Br J Haematol. 1980;46:263–268[Web of Science][Medline]
  104. Ludlam CA, Cash JD. Studies on the liberation of beta thromboglobulin from human platelets in vivo. Br J Haematol. 1976;32:239–247
  105. Williams AR, Chater BV, Allen KA, Sherwood MR, Sanderson JH. Release of beta thromboglobulin from human platelets by therapeutic intensities of ultrasound. Br J Haematol. 1978;40:113–142
  106. Ludlam CA. Evidence for the platelet specificity of beta-thromboglobulin and studies on its plasma concentration in healthy individuals. Br J Haematol. 1979;41:271–278[Web of Science][Medline]
  107. Schernthaner G, Silberbauer K, Muhlhauser I, Willvonseder R. Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4. Acta Med Austriaca Suppl. 1979;6:375–379[Medline]
  108. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood. 1981;57:199–202[Abstract/Free Full Text]
  109. Kutti J, Safai-Kutti S, Zaroulis CG, Good RA. Plasma levels of beta thromboglobulin and platelet factor 4 in relation to the venous platelet concentration. Acta Haematol. 1980;64:1–5[Web of Science][Medline]
  110. Lane DA, Ireland H, Wolff S, Ranasinghe E, Dawes J. Detection of enhanced in vivo platelet alpha-granule release in different patient groups—comparison of beta-thromboglobulin, platelet 4 and thrombospondin assays. Thromb Haemost. 1984;52:183–187[Web of Science][Medline]
  111. Cell G, Scattolo N, Cappellato MG, Girolami A, Strauss WE, Sasahara AA. Platelet factor 4 release induced by intravenous administration of heparin. Folia Haematol Int Mag Kl in Morphol Blutforsch. 1985;112:165–174
  112. Ikeda H, Nakayama H, Oda T. Soluble form of P-selectin in patients with acute myocardial infarction. Coronary Artery Dis. 1994;5:515–518[Web of Science][Medline]
  113. O'Connor CM, Gurbel PA, Serebruany VL. Usefulness of soluble and surface bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. Am J Cardiol. 1999;83:1345–1349[CrossRef][Web of Science][Medline]
  114. Lip GYH, Blann AD, Zarifis J, Beevers M, Lip PL, Beevers DG. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. J Hypertension. 1995;13:1674–1678[Web of Science][Medline]
  115. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood. 1994;83:1535–1541[Abstract/Free Full Text]
  116. Corash L. Measurement of platelet activation by fluorescence-activated flow cytometry. Blood Cells. 1990;16:97–106[Web of Science][Medline]
  117. Schmitz G, Rothe G, Andreas R. European working group on clinical cell analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost. 1998;79:885–896[Web of Science][Medline]
  118. Michelson AD, Furman MI. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol. 1999;6:342–348[CrossRef][Medline]
  119. Ruf A, Patscheke H. Flow cytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin Thromb Hemost. 1995;21:146–151[Web of Science][Medline]
  120. Lazarus AH, Wright JF, Blanchette V, Freedman J. Analysis of platelets by flow cytometry. Transfus Sci. 1995;16:353–361[CrossRef][Web of Science][Medline]
  121. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987;70:307–315[Abstract/Free Full Text]
  122. Kuhne T, Hornstein A, Semple J, Chang W, Blanchette V, Freedman J. Flow cytometric evaluation of platelet activation in blood collected into EDTA vs Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine and dipyridamole. Am J Hematol. 1995;50:40–45[Web of Science][Medline]
  123. Singh N, Gemmell CH, Daly PA, Yeo EL. Elevated platelet-derived microparticle levels during unstable angina. Can J Cardiol. 1995;11:1015–1021[Web of Science][Medline]
  124. Bock M, Gawaz M, Heim MU, Mempel W. Quality control of stored platelet concentrates by means of flow cytometry. Beitr Infusionsther transfusionsmed. 1994;32:397–400[Medline]
  125. FitzGerald GA, Healy C, Daugherty J. Thromboxane A2 biosynthesis in human disease. Fed Proc. 1987;46:154–158[Web of Science][Medline]
  126. Catella F, FitzGerald GA. Paired analysis of urinary thromboxane B2 metabolites in humans. Thromb Res. 1987;47:647–656[CrossRef][Web of Science][Medline]
  127. Pernerstorfer T, Stohlawetz P, Stummvoll G. Low dose aspirin does not lower in vivo platelet activation in healthy smokers. Br J Haematol. 1998;102:1229–1231[CrossRef][Web of Science][Medline]
  128. Lorenz RL, Hamm CW, Riesner H, Bleifeld W, Weber PC. A prospective study of the diagnostic value of urinary thromboxane in patients presenting with acute chest pain. J Intern Med. 1990;227:429–434[Web of Science][Medline]
  129. Fisher M, Zipser R. Increased exertion of immunoreactive thromboxane B2 in cerebral ischemia. Stroke. 1985;16:10–14[Abstract/Free Full Text]
  130. Rangemark C, Wennmalm A. Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. Clin Sci. 1991;81:11–15[Medline]
  131. Brox JH, Nordoy A. Prostacyclin and 51Cr release in cultured human endothelial cells. Haemostasis. 1982;12:345–352[Web of Science][Medline]
  132. Amrani KL, Stojanovic L, Mosesson MN, Shalev Y, Mosesson MW. Development of a whole platelet ELISA to detect circulating activated platelets. J Lab Clin Med. 1995;126:603–611[Web of Science][Medline]
  133. Matzdorff AC, Kemkes-Matthes B, Voss R, Pralle H. Comparison of BTG, flow cytometry and platelet aggregometry to study platelet activation. Haemostasis. 1996;26:98–106[Web of Science][Medline]
  134. Ikeda U, Yamamoto K, Shimada K. Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation, and cardiomyopathy. Clin Cardiol. 1997;20:7–10[Web of Science][Medline]
  135. Markovitz JH, Roubin GS, Parks JM, Bittner V. Platelet activation and restenosis after coronary stenting: flow cytometric detection of wound-induced platelet activation. Coron Artery Dis. 1996;7:657–665[Web of Science][Medline]
  136. Tsakiris DA, Riesen WF, Marbet GA. Lipoprotein (a) and hemostasis activation markers in angina pectoris. Dtsch Med Wochenschr. 1995;120:1109–1113[Medline]
  137. Hollander JE, Muttreja MR, Dalesandro MR, Shofer FS. Risk stratification of emergency department patients with acute coronary syndromes using P-selectin. J Am Coll Cardiol. 1999;34:95–105[Abstract/Free Full Text]
  138. Zeller JA, Tschoepe D, Kessler C. Circulating platelets show increased activation in patients with acute cerebral ischemia. Thromb Haemost. 1999;81:373–377[Web of Science][Medline]
  139. Rohrer MJ, Kestin AS, Ellis PA. High dose heparin suppresses platelet alpha granule secretion. J Vasc Surg. 1992;15:1008–1009
  140. Klinkhardt U, Kirchmaier CM, Westrup D. Ex vivo- in vitro interaction between aspirin, clopidogrel and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A. Clin Pharmacol Ther. 2000;67:305–313[CrossRef][Web of Science][Medline]
  141. Nurden P, Bihour C, Smith M, Raymond JM, Nurden AT. Platelet activation and thrombosis: studies in a patient with essential thrombocytopenia. Am J Hematol. 1996;51:79–84[CrossRef][Web of Science][Medline]
  142. Sturzenegger M, Beer JH, Rihs F. Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers. Stroke. 1995;26:63–69[Abstract/Free Full Text]
  143. Joseph JE, Harrison P, Mackie IJ, Machin SJ. Platelet activation markers and the primary antiphospholipid syndrome. Lupus. 1998;7:48–51

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M.-C. Chen, C.-F. Lin, H.-Y. Lei, S.-C. Lin, H.-S. Liu, T.-M. Yeh, R. Anderson, and Y.-S. Lin
Deletion of the C-Terminal Region of Dengue Virus Nonstructural Protein 1 (NS1) Abolishes Anti-NS1-Mediated Platelet Dysfunction and Bleeding Tendency
J. Immunol., August 1, 2009; 183(3): 1797 - 1803.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. M. van der Zee, E. Biro, Y. Ko, R. J. de Winter, C. E. Hack, A. Sturk, and R. Nieuwland
P-Selectin- and CD63-Exposing Platelet Microparticles Reflect Platelet Activation in Peripheral Arterial Disease and Myocardial Infarction
Clin. Chem., April 1, 2006; 52(4): 657 - 664.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
E. Arikan and S. Sen
Endothelial Damage and Hemostatic Markers in Patients with Uncomplicated Mild-to-Moderate Hypertension and Relationship with Risk Factors
Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 147 - 159.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
S. Sanderson, J. Emery, T. Baglin, and A.-L. Kinmonth
Narrative Review: Aspirin Resistance and Its Clinical Implications
Ann Intern Med, March 1, 2005; 142(5): 370 - 380.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. Houel, E. Mazoyer, B. Boval, M. Kirsch, E. Vermes, L. Drouet, and D. Y. Loisance
Platelet activation and aggregation profile in prolonged external ventricular support
J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 197 - 202.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. Y.H. Lip
Hypertension, Platelets, and the Endothelium: The "Thrombotic Paradox" of Hypertension (or "Birmingham Paradox") Revisited
Hypertension, February 1, 2003; 41(2): 199 - 200.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
S. Kamath, A. D. Blann, B. S. P. Chin, F. Lanza, B. Aleil, J. P. Cazenave, and G. Y. H. Lip
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy
Eur. Heart J., November 2, 2002; 23(22): 1788 - 1795.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Kamath, A. D. Blann, B. S. P. Chin, and G. Y. H. Lip
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation
J. Am. Coll. Cardiol., August 7, 2002; 40(3): 484 - 490.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. G.C. Spencer, D. Gurney, A. D. Blann, D. G. Beevers, and G. Y.H. Lip
Von Willebrand Factor, Soluble P-Selectin, and Target Organ Damage in Hypertension: A Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Hypertension, July 1, 2002; 40(1): 61 - 66.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kamath, S.
Right arrow Articles by Lip, G.Y.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamath, S.
Right arrow Articles by Lip, G.Y.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?